Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT
| Image |  |
|---|---|
| Description | scientific article published on 04 September 2020 |
| Author/s |
author: Ville Pettilä Annukka Vahtera |
| Publication date | September 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |